Abstract
Approximately 40% of childhood cancer is acute leukemia and non-Hodgkin lymphoma [1,2], and nearly 85% of all childhood leukemia in the United States and Europe is acute lymphocytic leukemia (ALL) [2, 3]. ALL is of worldwide distribution, and everywhere it tends to be predominantly a disease of children, with most patients being under ten years of age [3–7]. According to the Third National Cancer Survey [8], the average incidence rate in the United States for ALL in children ages 0–14 years is 2.4 per 100,000. In the United States there is no significant regional variation in the incidence of ALL. Nevertheless, the northern region has the lowest incidence rate (1.8/100,000), whereas the southern and western regions of the country share the highest incidence rate (2.9/100,000). The same survey showed a higher incidence rate (2.7/100,000) in males than in females (2.0/100,000) [8]. Most studies have reported a lower incidence of ALL in American blacks [8–11]. Childhood ALL has a peak incidence at about four years of age in white children [3, 8, 12]. Interestingly, American blacks have a different age of peak incidence, 10–14 years of age [8]. In the United States, it has been documented that the frequency of leukemia is more closely associated with socio-economic status than ethnic group [9]. As the socio-economic status increases, the frequency of ALL rises accordingly [13].
This investigation was supported by grants number CA09128 and CA-25408, awarded by the National Cancer Institute, DHEW
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Castleberry RP: Current trends in childhood acute lymphocytic leukemia and non-Hodgkin’s lymphoma. A1 Jour Med Sci 18 (3): 243–248, 1981.
Borella L, Sen L, Dow LW, Casper JT: Cell differentiation antigens versus tumor related antigens in childhood acute lymphoblastic leukemia (ALL). Clinical significance of leukemia markers. Hematol Bluttrans 20: 77–85, 1977.
Altman AJ, Schwartz AD: The Leukemias. Malignant Diseases of Infancy, Childhood and Adolescence (MPCP), Vol 19, 169, 1978.
The Lancet, Epidemiology of leukemia. Lancet 1 (741): 82–3, 1972.
Greaves MF, Janossy G, Roberts M, Rapson NT, Ellis RB, Chessels J, Lister TA, Catovsky D: Membrane phenotyping: Diagnosis, monitoring and classification of acute 4 lymphoid7 leukaemias. Hematol Bluttrans 20: 61–75, 1977.
Merck Manual, 13th Edition, (eds. Berkow, R., et al.) Merck Sharp and Dohme Res. Lab.; Rahway, NJ, 325–329, 1977.
Essex M: Can feline oncornaviruses cause leukemia in man? Oncology 25: 345–356, 1972.
Third National Cancer Survey: Incidence Data. National Cancer Institute Monograph 41, March, 1975. DHEW Publication No. (NIH) 75–787, USDHEW, Public Health Service, NIH, National Cancer Institute, Bethesda, MD.
MacMahon B, Koller EK: Ethnic differences in the incidence of leukemia. Blood 12: 1–10, 1957.
Szklo M, Gordis L, Tonascia J, Kaplan E: The changing survivorship of white and black children with leukemia. Cancer 42: 59–66, 1978.
Olisa EG, Chandra R, Jackson MA, Kennedy J, Williams AO: Malignant tumors in American black and Nigerian children: A comparative study. JNCI 55 (2): 281–284, 1975.
Robbins SL, Cotran RS: Leukemias, Pathologic Basis of Disease 2nd Ed., W.B. Saunders Co., Philadelphia, p. 779, 1979.
Githens JH, Elliot FE, Saunders LH: The relationship of socioeconomic factors to incidence of childhood leukemia. Public Health Reports 80 (7): 573–578, 1965.
Humphrey GB, Blackstock R, Filler J: Cell surface markers in acute lymphoblastic leukemia. Ann Clin Lab Sci 10 (3): 169–80, 1980.
Kumar S, Carr TF, Evans DI, Morris-Jones P, Hann IM: Prognostic significance of cell surface markers in childhood acute lymphoblastic leukemia. Clin Lab Haematol 1:121– 128, 1979.
Aiuti F, Lacava V, Fiorilli M, Ciarla MV: Lymphocyte surface markers in lymphoproliferative disorders. Acta Haematol 50: 275–283, 1973.
Chessells JM, Hardisty RM, Rapson NT, Greaves MF: Acute lymphoblastic leukemia in children: Classification and prognosis. Lancet 2 (8052–53): 1307–9, 1977.
Nadkarni JJ, Nadkarni JS, Advani SH: Surface markers in human lymphoid leukaemias. Ind J Cancer 15: 43–47, 1978.
Huhn D, Thiel E, Rodt H: Classification of normal and malignant lymphatic cells using acid phosphatase and acid esterase. Klin Wochenschr 58: 65–71, 1980.
Foon KA, Billing RJ, Terasaki PI: Dual B and T markers in acute and chronic lymphocytic leukemia. Blood (55)1: 16–20, 1980.
Rodt H, Netzel B, Thiel E, Jager G, Huber D, Haas R, Gotze D, Thierfelders: Classification of leukemia cells with T and O ALL specific antisera. Hematology and Blood Trans 20: 87–96, 1977.
Sallan SE, Chess L, Frei E III, O’Brien, Nathan DG, Strominger JL, Schlossman SF: Utility of B-and T-cell-specific antisera in the classification of human leukemias. In: Differentiation of Normal and Neoplastic Hematopoietic Cells (eds. Clarkson B, Marks PA, Till JE ), p. 479–483, Cold Spring Harbor Laboratory, 1978.
Vogler LB, Crist WM, Sarrif AM, Pullen DJ, Bartolucci AA, Falletta JM, Dowell B, Humphrey GB, Blackstock R, van Eys J, Metzgar RS, Cooper MD: An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre–B leukemia. Blood 58 (1): 135–140, 1981.
Reid MM, Craft AW, Walker W: Poor prognosis of T–cell leukemia in children, (letter) Lancet 2 (8047): 1074–1075, 1977.
Sallon SE, Ritz J, Pesando J, Gelber R, O’Brien C, Hitchcock S, Caral F, Schlossman S: Cell surface antigens: Prognostic implications in childhood acute lymphoblastic leukemia. Blood 55: 395–402, 1980.
Dow LW, Borlla L, Sen L, Aur RJ, George SL, Mauer AM, Simone JV: Initial prognostic factors and lymphoblasterythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood 50: 671–682, 1977.
Roper M, Crist W, Ragab A, Pullen J, Humphrey GB, Boyett J, Metzgar R, van Eys J, Nix W, Cooper M: Pre-B cell leukemia differs in its response to therapy. Blood 58 (5): 150A, 1981.
Jaffe S, Berard CW: Lymphoblastic lymphoma; A term rekindled with new precision. Ann Inter Med 89 (3): 415–417, 1978.
Nathwani BN, Kim H, Rappaport H: Malignant lymphoma, lymphoblastic. Cancer 38: 964–983, 1976.
Nadler LM, Reinherz EL, Weinstein HJ, D’Orsi CJ, Schlossman SF: Heterogeneity of T–cell lymphoblastic malignancies. Blood 55 (5): 806–810, 1980.
Miller RW: Delayed radiation effects in atomic–bomb survivors. Science. 166: 569–574, 1969.
Polley JR, Borges W, Yamazaki T: Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med 13: 311, 1952.
Potolsky A, Creger WP: Radiation and drug therapies, and leukemia. Annu Rev Med 24: 75–82, 1973.
Lange RD, Moloney WC, Yamazaki T: Leukemia in atomic bomb survivors. Blood 9: 574, 1954.
Moloney WC, Kastenbaum MA: Leukemogenic effects of ionizing radiation on atomic bomb survivors in Hiroshima City. Science 121: 308, 1955.
March HC: Leukemia in radiologists in a 20 year period. AM J M Sc 220: 282, 1950.
Ulrich H: The incidence of leukemia in radiologists. New Engl J Med 234: 45, 1946.
Schwartz AD, Lee H, Baum ES: Leukemia in children with Wilms’ tumor. J Pediatr 87: 374–376, 1975.
Aksoy M: Benzene and leukemia. Lancet 1: 441, 1978.
Vigliana EC, Forni A: Benzene and leukemia. Environ Res 11: 122–127, 1976.
Manning MD, Carroll BE: Some epidemiological aspects of leukemia in children. JNCI 19 (6): 1087–1094, 1957.
Miller RW: Neoplasia and Down’s syndrome. Ann NY Acad Sci 171: 637–644, 1970.
German J, Bloom D, Passarge E: Bloom’s syndrome. Surveillance for cancer in affected families. Clin Genet 12 (3): 162–168, 1977.
O’Gorman Hughes DW: Aplastic anaemia in childhood. III. Constitutional aplastic anaemia and related cytopenias. Med J Aust 1: 519–526, 1974.
Hecht F, McCaw BK, Koler RD: Ataxia–telangiectasia–clonal growth of translocation lym¬phocytes. N Engl J Med 289: 286–291, 1973.
Lilly F, Pincus T: Genetic control of murine viral leukemogenesis. Adv Can Res 17:231– 277, 1973.
Meruelo D, Lieberman M, Ginzton N, Deak B, McDevitt HO: Genetic control of radiation leukemia virus–induced tumorigenesis. I. Role of the major murine histocompatibility complex, H-2. J Exp Med 146: 1079–1087, 1977.
Meruelo D: A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation–induced leukemia virus. J Exp Med 149: 898–909, 1979.
Sanderson AR, Mahour GH, Jaffe N and Das L: Incidence of HLA antigens in acute lymphocytic leukemia. Transplantation 16: 672–673, 1973.
Rogentine GN, Trapani RJ, Yankee RA and Henderson ES: HL-A antigens and acute lymphocytic leukemia: The nature of the HL–A2 association. Tissue Antigens 3: 470–476, 1973.
Albert ED, Nisperos B, Thomas ED: HLA antigens and haplotypes in acute leukemia. Leukemia Research 1: 261–269, 1977.
Grumet FC: HLA and disease associations. Transplant Proc 9: 1839–1844, 1977.
Lawler SD, Klouda PT, Smith PG, Till MM and Hardesty RM: Survival and the HLA system in acute lymphoblastic leukemia. Brit Med J 1: 547–548, 1974.
Klouda PT, Lawler SD, Till MM, Hardesty RM: Acute lymphoblastic leukemia and HLA: a prospective study. Tissue Antigens 4: 262–265, 1974.
Davey FR, Lachant NA, Dock NL, Hubbell C, Stockman JA and Henry JB: HLA antigens and childhood acute lymphocytic leukemia. Brit J Haematology 47 (2): 211–220, 1981.
DeBruyere M, Cornu G, Heremans–Bracke T, Malchaire J, Sokal G: HLA haplotypes and long survival in childhood acute lymphoblastic leukemia treated with transfer factor. Brit J Haematology 44 (2): 243–251, 1980.
Michel K, Hubbel C, Dock NL, Davey FR: Correlation of HLA-Drw3 with childhood acute lymphocytic leukemia. Arch Pathol Lab Med 105: 560, 1981.
Revesz T, Bencz’r M, Gyodi E, Petranyi GG, Schuler D: The association of HLA-DR5 antigen with longer survival in childhood leukemia. Brit J Haematol 48: 508–509, 1981.
Budowle B, Acton RT, Barger BO, Blackstock R, Crist W, Go RCP, Humphrey GB, Ragab A, Roper M, Vietti T, Dearth J: Properdin factor B and acute lymphocytic leukemia (ALL) Cancer 50: 2369–2371, 1982.
Pike MC, Smith PG: Clustering of Cases of Hodgkin’s Disease and Leukemia. Cancer 34: 1390–1394, 1974.
Smith PG, Pike MC, Till MM, Hardisty RM: Epidemiology of Childhood Leukemia in Greater London: A search for evidence of Transmission assuming a possibly long latent period. Br J Cancer 33: 1–8, 1975.
Till MM, Hardisty RM, Pike MC, Doll R: Childhood Leukemia in Greater London: A search for evidence of clustering. Brit Med J 3: 755–758, 1967.
Lock SP, Merrington M: Leukemia in Lewisham (1957–63). Brit Med J 3: 759–760, 1967.
Knox G: Epidemiology of childhood leukemia in Northumberland and Durham. Brit J Prev Soc Med 18: 17–24, 1964.
Mainwaring D: Epidemiology of acute leukemia of childhood in the Liverpool area. Brit J Prev Soc Med 20: 189–194, 1966.
Meighan SS, Knox G: Leukemia in childhood: epidemiology in Oregon. Cancer 18: 811–814, 1965.
Heath CW, Hasterlik RJ: Leukemia among children in a suburban community. Amer. J Med 34: 796–812, 1963.
Pike MC, Smith PG: A case–control approach to examine diseases for evidence of contagion, including diseases with long latent periods. Biometrics 30: 263–279, 1974.
Theilen GH: Public health aspects of animal tumor viruses. Theirogenology 6: 331–342, 1976.
Cotter SM: Feline leukemia virus induced disorders in the cat. Vet Clin N Amer 6: 367–378, 1976.
Hardy WD Jr, Old LJ, Hess PW, Essex M, Cotter S: Horizontal transmission of feline leukaemia virus. Nature 244: 266–269, 1973.
Jarrett W, Jarrett O, Mackey L et al.: Horizontal transmission of leukemia virus and leukemia in the cat. JNCI 51: 833–841, 1973.
Piper CE, Abt DA, Ferrer JF et al.: Seroepidemiological evidence of horizontal transmission of bovine C-type virus. Cancer Res 35 (10): 2714–2716, 1975.
Dutcher RM, Larkin EP, Marshak RR: Virus-like particles in cow’s milk from a herd with high incidence of lymphosarcoma. JNCI 33: 1055–1064, 1975.
Kettman R, Portetelle D, Mammerick M, Cleuter Y, DeKegel D, Galou M, Chysdael J, Burney A, Chantrenne H: Bovine leukemia virus: An exogenous RNA oncogenic virus. Proc Natl Acad Sci 73: 1014–1018, 1976.
Ferrer JF, Abt DA, Bhatt DM, Marshak RR: Studies on the relationship between infection with bovine C–type virus, leukemia and persistent lymphocytosis in cattle. Cancer Res 34: 893–900, 1974.
Kawakami TG, Huff SD, Buckley PM, Dungworth DL, Snyder SP, Gilden RV: C–type virus associated with gibbon lymphosarcoma. Nature 225: 170–171, 1972.
Ioachim HL: Prevention of gross virus-induced leukemia in progeny of immunized female rats. Cancer Res 30: 2661–2664, 1970.
Jarrett WFH, Crawford E, Martin WB, Davie F: A Virus-like Particle associated with Leukemia (Lymphosarcoma). Nature 202: 567–569, 1964.
Allen DW, Cole P: Viruses and human cancer. N Engl J Med 286: 70–82, 1972.
Francis DP, Essex M: Leukemia and lymphoma: Infrequent manifestations of common viral infections? A review. J Infect Dis 138 (6): 916–923, 1978.
Baxt W et al.: Human leukemic cells containing reverse transcriptase associated with a high molecular weight virus–related RNA. Nature 240: 72, 1972.
Holland JF: The acute leukemias: In: Cecil Text of Med. 5th Ed. Vol. II, p. 1813, (eds., Beeson PB, McDermott W, Wyngaarden JB ). WB Saunders Co., Philadelphia, 1979.
Gallo RC, Yong DS, Ting RC: RNA–dependent DNA polymerase of human acute leukemic cells. Nature 228: 927, 1970.
Ioachim HL, Sabbath M, Andersson B, Keller S: Viral and chemical leukemia in the rat: Comparative study. JNCI 47 (1): 161–168, 1971.
Kalyanaraman VS, Sarngadharan MG, Nakao Y, Ito Y, Aoki T, Gallo RC: Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in the sera of leukemia patients in Japan, Proc Natl Acad Sci USA 79: 1653–1657, 1982.
Catovsky D, Rose M, Goolden AWG, White JM, Bourikas G et al.: Adult T–cell lymphoma-Leukaemia in Blacks from the West Indies. Lancet 8273: 643, 1982.
Hinuma Y, Nagata K, Hanaoka M, et al.: Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78: 6476–6480, 1981.
Gallo RC, Blattner WA, Reitz MS Jr, Ito Y: HTLV: The Virus of adult T-cell leukaemia in Japan and Elsewhere. Lancet 8273: 683, 1982.
Mier JW, Gallo RC: Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA 77: 6134–6138, 1980.
Essex M: Adult T-cell leukemialymphoma: Role of a human retrovirus. JNCI 69(4): 981– 985, 1982.
Gallo RC, Wong–Staal F: Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. Blood 60 (3): 545–557, 1982.
Donham KJ, Berg JW, Sawin RS: Epidemiologic relationship of bovine population and human leukemia in Iowa. Amer J Epidemiol 112 (1): 80–92, 1980.
Gupta P, Ferrer JF: Expression of Bovine Leukemia Virus Genome Is Blocked by a Non-immunoglobulin Protein in Plasma from infected cattle. Science 215: 405–407, 1982.
Ferrer JF, Kenyon SJ, Gupta P: Milk of Dairy Cows Frequently contains a Leukemogenic Virus. Science 213: 1014–1016, 1981.
Reif JS: Pet associated zoonoses. In: Current Vet Therapy VI (eds. Kirk RW et al.), p. 1433, WB Saunders Co., Philadelphia, 1977.
Levy SB: Cat leukemia: A threat to man? N Engl J Med 290 (9): 513–14, 1974.
Gilmore CE, Holzworth J: Naturally occurring feline leukemia: Clinical, pathologic, and differential diagnostic features. JAVMA 158: 1013–1025, 1971.
Jarrett O, Laird HM, Hay D, Jarrett WFH: Feline leukemia. J Small Anim Pract 10: 599–603, 1969.
Benveniste RE, Todaro GJ: Evolution of type C viral genes: Origin of feline leukemia virus. Science 190: 886–888, 1975.
Hardy WD Jr., Hess PW, MacEwen EG, McClelland AJ, Zuckerman EE, Essex M, Cotter SM, Jarrett O: Biology of Feline leukemia virus in the natural environment. Cancer Res 36: 582–588, 1976.
Hardy WD Jr: Immunopathology of Lymphoreticular Neoplasms (eds. Twomey JJ and Good RA), 129–180. Plenum, New York, 1978.
Cotter SM: Update on Feline Leukemia. In: Proceedings: American Animal Hospital Association 46th Annual Meeting, 119–121, 1979.
Francis DP, Essex M, Hardy WD, Jr.: Excretion of feline leukaemia virus by naturally infected pet cats. Nature 269: 252–254, 1977.
Gardner MB, Rongey RW, Johnson EY, DeJournett R, Huebner JR: C–type tumor virus particles in salivary tissue of domestic cats. JNCI 47: 561–565, 1971.
Hardy WD, Jr., Geering G, Old LJ, deHarven E, Brodey RS, McDonough S: Feline leukemia virus: occurrence of viral antigens in the tissues of cats with lymphosarcoma and other diseases. Science 166: 1019–1021, 1969.
Hoover EA, Olsen RG, Mathes L et al.: Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow and saliva of cats. Cancer Res 37: 3707–3710, 1977.
Ladiges WC, DiGiacomo RF, Wardrop KJ, Hardy WD, Jr.: Prevalence and sequelae of feline leukemia virus infection in laboratory cats. JAVMA 179 (11): 1206–1207, 1981.
Hardy WD, Jr: The Virology, Immunology and Epidemiology of the Feline Leukemia Virus. In: Feline Leukemia Virus, (eds. Hardy WD, Jr, Essex M, McClellan AJ ), 33–78. Elsevier North Holland, Inc. 1980.
Holzworth J: Leukemia and related neoplasms of the cat. I. Lymphoid neoplasms. JAV¬MA 136: 47–69, 1960.
Neilsen SW: Neoplastic diseases: In: Catcott: Feline Medicine and Surgery, American Veterinary Publication, Wheaton, 1964.
Laird HM, Jarrett O, Crighton GW and Jarrett WFH: An electron microscopic study of virus particles in spontaneous leukemia in the cat. JNCI 41: 867–878, 1968.
Jarrett O, Laird HM, Hay D: Growth of feline leukemia virus in human cells. Nature 224: 1208–1209, 1969.
Hardy WD, Jr., Suckerman EE, MacEwen EG, et al.: A feline leukemia and sarcoma virus induced tumor specific antigen. Nature 270: 249–251, 1977.
Essex M, Cotter SM, Carpenter JL: Feline virus–induced tumors and the immune response: Recent developments. Am J Vet Res 34: 809–812, 1973.
Hoover EA, Olsen RG, Hardy WD, Jr., Schaller JP, Mathes LE: Feline leukemia virus infection: Age-related variation in response of cats to experimental infection. JNCI 57: 365–369, 1976.
Essex M, Cotter SM, Carpenter JL, Hardy WD, Jr., Hess P, Jarrett W, Schaller JP, Yohn DS: Feline oncornavirus-associated cell membrane antigen II. Antibody titers in healthy cats from household and laboratory colony environments. JNCI. 54: 631, 1975.
Jarrett O: Growth of feline leukemia virus in human, canine, and porcine cells. Proc. 4th Int Symp on Comparative Leukemia Research, Cherry Hill, NJ, 1969.
Azocar J, Essex M: Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus. JNCI 63: 1179–1184, 1979.
Olsen RG, Mathes LE, Yohn DS: In Comparative Leukemia Research 1973, (eds. Ito Y, Dutcher RM ), Krager/Basel, 419–429, 1975.
Caldwell GC, Baumgartener L, Carter C, Cotter S, Currier R, Essex M, Hardy W, Olson C, Olsen R: In: Comparative Leukemia Research 1975, (eds. Clemmesen J, Yohn DS ), Karger/Basel, 238–241, 1976.
Sordillo PP, Markovich RP, Hardy WD Jr: Search for evidence of feline leukemia virus infection in Humans with leukemias, lymphomas, or soft tissue sarcomas. JNCI 69(2): 333– 337, 1982.
Francis DP, Essex M, Cotter SM, Gutensohn N, Jakowski R, Hardy WD Jr: Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. Cancer Lett 12: 37–42, 1981.
Hardy WD Jr, McClelland AJ, Zuckerman EE, et al.: Development of virus nonproducer lymphosarcomas in pet cats exposed to FeLV. Nature 288: 90–92, 1980.
Sliski AH, Essex M, Meyer C, Todaro GJ: Feline oncornavirus associated cell membrane antigen (FOCMA): Expression on feline sarcoma virus–transformed nonproducer mink cells. Science 196: 1336–1339, 1977.
Bross ID, Gibson R: Cats and childhood leukemia. J Med (BASEL) 1: 180–187, 1970.
Penrose M: Cat Leukaemia. Brit Med J 1: 755, 1970.
Bross ID, Bertell R, Gibson R: Pets and adult leukemia. AJPH 62 (11): 1520–31, 1972.
Fasal E, Jackson EW, Klauber MR: Mortality in California Veterinarians. J Chron Dis 19: 293–306, 1966.
Botts RP, Edlavitch S, Payne G: Mortality of Missouri Veterinarians. JAVMA 149 (5): 499–504, 1966.
Schnurrenberger PR, Martin RJ, Walker JF: Mortality in Illinois Veterinarians. JAVMA, 170 (10): 1071–1075, 1977.
Blair A, Hayes HM Jr: Cancer and other causes of death among US veterinarians, 1966– 1977. Int J Cancer 25: 181–185, 1980.
Guthensohn N, Francis DP, Hardy WD, Jr., Essex M: In: Viruses in Naturally Occurring Cancer (eds. Essex M, Todaro G, ZurHausen H ), Cold Spring Harbor Lab, New York, 1980.
Schneider R: The natural history of malignant lymphoma and sarcoma in cats and their associations with cancer in man and dog. JAVMA 157 (11): 1753–1758, 1970.
Hanes B, Gardner MB, Loosli CG, Heidbreder G, Kogan B, Marylander H, Huebner RJ: Pet association with selected human cancers: A household questionnaire survey. JNCI 45 (6): 1155–1162, 1970.
Safety Standards for Research Involving Oncogenic Viruses, Department of Health, Edu¬cation and Welfare publication (NIH) 75–790, National Cancer Institute, 1974.
Essex M, Hardy WD Jr., Cotter SM, et al.: Naturally occurring resistant feline oncornavirus infections in the absence of disease. Infection and Immunity 11: 470–475, 1975.
Hardy WD Jr: Immunodiffusion studies of feline leukemia and sarcoma. JAVMA 158: 1060, 1971.
Maruyama K, Dmochowski L, Richard CG: A search for antural antibody against feline and murine leukemia antigen by mixed hemadsorption test. JAVMA 158: 1076, 1971.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Malone, G.E., Roseman, J., Crist, W.M., Acton, R.T. (1983). A Review of Evidence that the Feline Leukemia Virus (FeLV) might be causative in Childhood Acute Lymphocytic Leukemia (ALL). In: Humphrey, G.B., Grindey, G.B., Dehner, L.P., Acton, R.T., Pysher, T.J. (eds) Adrenal and Endocrine Tumors in Children. Cancer Treatment and Research, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3891-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3891-8_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3893-2
Online ISBN: 978-1-4613-3891-8
eBook Packages: Springer Book Archive